Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
Francesco Dituri(Gastroenterology Hospital "Saverio de Bellis"), Gianluigi Giannelli(Gastroenterology Hospital "Saverio de Bellis")
Cited by 94
Related Papers
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
|Journal of Hepatology|2016|641
Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma†
|Hepatology|2008|140
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin‐332/α3 integrin axis recovery of focal adhesion kinase ubiquitination
|Hepatology|2016|102
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins
|Hepatology|2007|71
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis
|Cell Death and Differentiation|2020|68